Delivery Order SPE2DB20D3101-SPE2DB24FRPM8
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,485.56 fixed-price delivery order is for the supply of GARDASIL 9 vaccine syringes, a medical product used for immunization. The order has a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,411.39 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,610.17 firm fixed-price contract is for the delivery of GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,867.35, is for the delivery of GARDASIL 9 syringes (0.5 mL) to support military healthcare programs. The contract is a firm-fixed-price, non-set-aside award with a completion date of November 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $9,672.03, is for Gardasil 9 syringes (0.5 mL) and has a completion date of January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $10,536.49 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of GARDASIL 9 SYRINGE 0.5ML. The contract has an ultimate completion date of June 27, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,520.37 firm fixed price delivery order is for the supply of GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,804.08 delivery order is for the supply of 4,565,936,210 units of the GARDASIL 9 vaccine syringe, a critical medical supply. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,616.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,206.61 firm-fixed-price contract is for the delivery of GARDASIL 9 syringes, a vaccine product. It is not designated as a set-aside contract, indicating open competition. The contract has an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...